Search

Search Constraints

Start Over Filtering by: Journal or Parent Publication Title Molecular Cancer Therapeutics Remove constraint Journal or Parent Publication Title: Molecular Cancer Therapeutics

Search Results

  • BET inhibition sensitizes immunologically-cold Rb-deficient prostate cancer to immune checkpoint blockade
  • An Infrared Dye-Conjugated Virus-like Particle for the Treatment of Primary Uveal Melanoma
  • PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus
  • ADP-Ribosylation Levels and Patterns Correlate with Gene Expression and Clinical Outcomes in Ovarian Cancers
  • Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer
  • Disruption of STAT3 by Niclosamide Reverses Radioresistance of Human Lung Cancer
  • Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer
  • Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma
  • Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non-Small Cell Lung Cancer
  • Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O-6-methylguanine-DNA methyltransferase activity